Stockreport

Why Madrigal Pharmaceuticals (MDGL) Is Down 9.7% After Rezdiffra's Near US$1 Billion Debut Year [Yahoo! Finance]

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com
PDF newly launched MASH therapy Rezdiffra generated close to US$1 billion in net sales in its first full year on the market. Alongside these results, Madrigal highlighted [Read more]